Plain-English translation of NCT06203548 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new continuous scanning technology called continuous CAP to measure changes in liver fat over time. You'll participate in a 6-month lifestyle improvement program, and researchers will use advanced imaging scans to track how much fat is in your liver and whether it decreases as you make healthier choices.
Current methods for measuring liver fat can be limited or uncomfortable. This study aims to develop a better, easier way to track how well lifestyle changes are working for people with fatty liver disease.
You likely qualify if…
You likely don't qualify if…
You will attend four clinic visits over 6 months: a screening visit, a baseline visit, a 3-month check-in, and a final 6-month visit. At these visits, you'll have blood tests, abdominal ultrasounds, and two types of advanced scans (continuous CAP and MRI) to measure liver fat. You'll also participate in a lifestyle improvement program focused on diet and exercise to help reduce fat in your liver.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Hong Kong
Chinese University of Hong Kong
Enrollment target
~150 participants
Started
February 2024
Primary completion
January 2027
Age range
18 Years – 65 Years
Last updated on clinicaltrials.gov in August 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Vincent Wong, MD
Chinese University of Hong Kong
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.